# Nicholas Butowski

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nicholas-butowski/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,217 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 69 |
| i10-index | 153 |
| Last Known Institution | University of California, San Francisco |
| OpenAlex ID | https://openalex.org/A5090305344 |
| ORCID iD | https://orcid.org/0000-0001-5162-2406 |
| Works | 607 |

## Researcher papers

- [Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma](https://scholariq.org/papers/neoadjuvant-anti-pd-1-immunotherapy-promotes-a-survival-benefit-with/)
- [Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma](https://scholariq.org/papers/association-of-maximal-extent-of-resection-of-contrast-enhanced-and-non-contrast/)
- [Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/central-nervous-system-cancers-version-3-2020-nccn-clinical-practice-guidelines/)
- [Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma](https://scholariq.org/papers/phase-ii-study-of-erlotinib-plus-temozolomide-during-and-after-radiation-therapy/)
- [NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017](https://scholariq.org/papers/nccn-guidelines-insights-central-nervous-system-cancers-version-1-2017/)
- [NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022](https://scholariq.org/papers/nccn-guidelines-insights-central-nervous-system-cancers-version-2-2022/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [ATP Synthase and ATPases Research](https://scholariq.org/topics/atp-synthase-and-atpases-research/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

## Researcher university

- [University of California, San Francisco](https://scholariq.org/institutions/university-of-california-san-francisco/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.